Cipla Latest News

  1. The company in partnership with MMV launches quality-assured RAS
    Date:26-07-2017
  2. RAS is a life-saving, pre-referral intervention for the management of severe malaria in young children
    Date:26-07-2017
  3. The company and Novartis are in talk to co-market anti-asthmatic drug Xolair in India
    Date:14-07-2017
  4. Xolair (omalizumab) is an injectable prescription medicine used to treat moderate to severe persistent asthma
    Date:14-07-2017
  5. The company has entered into an agreement for sale on June 7, 2017
    Date:09-06-2017
  6. The company has entered into an agreement for sale on June 7, 2017
    Date:09-06-2017
  7. Cipla Vet and Cipla Agrimed have ceased to be subsidiaries of Inyanga Trading 386 Proprietary with effect from June 01, 2017
    Date:02-06-2017
  8. Cipla Vet and Cipla Agrimed have ceased to be subsidiaries of Inyanga Trading 386 Proprietary with effect from June 01, 2017
    Date:02-06-2017
  9. CARE has reaffirmed ‘A1+’ rating to Cipla’s short-term bank facilities
    Date:18-05-2017
  10. Cipla has informed that Credit Analysis and Research (CARE) has reaffirmed a CARE A1+ rating to the various existing short-term bank facilities. The Company is not availing long-term bank facilities and accordingly the rating f...

    Date:16-05-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
Request a Call Back
We will guide you on how to find
the Right stocks at the Right prices.
Mobile
Invalid Mobile Number
x
Thank you for
contacting us.
We will call you
shortly.